FDA
-
-
-
-
-
-
-
Hoth Completes Animal Safety Study of Proprietary BioLexa Platform for the Treatment of Atopic Dermatitis
-
-
-
-
-
-
-
Hoth Therapeutics Announces the Appointment of Dr. William Weglicki, M.D. to Scientific Advisory Board
-
-
-
-
-
-
-
Spherix (SPEX) Issues Update to Shareholders
-
-
-
-
-
-
-
Hoth Therapeutics, Inc. Announces the Addition of Dr. Lawrence A. Schachner, M.D. and Dr. Vincent C.O. Njar, Ph.D. to the Company's Scientific Advisory Board
-
-
-
-
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

